Shopping Cart
- Remove All
- Your shopping cart is currently empty
GSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 45 € | In Stock | |
2 mg | 65 € | In Stock | |
5 mg | 112 € | In Stock | |
10 mg | 183 € | In Stock | |
25 mg | 311 € | In Stock | |
50 mg | 448 € | In Stock | |
100 mg | 609 € | In Stock | |
200 mg | 821 € | In Stock | |
1 mL x 10 mM (in DMSO) | 132 € | In Stock |
Description | GSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury. |
Alias | GSK-329, GSK 329 |
Molecular Weight | 472.25 |
Formula | C19H14Cl2F3N5O2 |
Cas No. | 1268490-12-5 |
Smiles | CNc1cc(Oc2c(Cl)cc(NC(=O)Nc3cccc(c3)C(F)(F)F)cc2Cl)ncn1 |
Relative Density. | 1.554 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 245 mg/mL (518.79 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.